Ignite Creation Date:
2024-05-06 @ 10:27 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03260712
Status:
COMPLETED
Last Update Posted:
2023-11-03
First Post:
2017-08-08
Brief Title:
Pembrolizumab in Biliary Tract Cancer
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-08
First Submit QC Date:
August 21 2017
Study First Post Date:
2017-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-02
Last Update Post Date:
2023-11-03
Last Update Post Date Type:
ACTUAL